Craig S. Eastwood
2020
In 2020, Craig S. Eastwood earned a total compensation of $781K as Former Chief Financial Officer at CytoDyn, a 1,296% increase compared to previous year.
Compensation breakdown
| Option Awards | $159,115 |
|---|---|
| Salary | $192,682 |
| Stock Awards | $180,000 |
| Other | $249,213 |
| Total | $781,010 |
Eastwood received $249.2K in other compensation, accounting for 32% of the total pay in 2020.
Eastwood also received $159.1K in option awards, $192.7K in salary and $180K in stock awards.
Rankings
In 2020, Craig S. Eastwood's compensation ranked 9,584th out of 13,090 executives tracked by ExecPay. In other words, Eastwood earned more than 26.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,584 out of 13,090 | 27th |
Division Manufacturing | 4,109 out of 5,624 | 27th |
Major group Chemicals And Allied Products | 1,678 out of 2,257 | 26th |
Industry group Drugs | 1,470 out of 1,957 | 25th |
Industry Pharmaceutical Preparations | 1,083 out of 1,462 | 26th |
Source: SEC filing on September 1, 2020.
Eastwood's colleagues
We found three more compensation records of executives who worked with Craig S. Eastwood at CytoDyn in 2020.